Candesartan cilexetil is rapidly hydrolyzed in vivo to its active metabolite candesartan—a selective angiotensin II (Ang II) ARB that inhibits RAS to treat DCM-associated heart failure (89). This evidence concerns the gene AGT and heart failure.